Penicillin-Binding Proteins, Mechanism and Inhibition
青霉素结合蛋白、机制和抑制
基本信息
- 批准号:6324997
- 负责人:
- 金额:$ 24.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-04-01 至 2005-03-31
- 项目状态:已结题
- 来源:
- 关键词:Escherichia coli Staphylococcus aureus antibiotics bacterial proteins beta lactam antibiotic binding proteins cell wall cephalosporins crystallization drug design /synthesis /production drug discovery /isolation microorganism metabolism molecular assembly /self assembly molecular cloning pharmacokinetics transpeptidation
项目摘要
DESCRIPTION: (Applicant's Description) Penicillin-binding proteins (PBPs) are a
group of enzymes involved in a number of functions in the assembly and
regulation of bacterial cell wall. These enzymes are the targets of beta-lactam
antibiotics for inhibition of bacterial growth. A multidisciplinary approach
has been outlined for the study of PBPs, which builds on the mechanistic
findings from this laboratory presented as Preliminary Results. Pour Specific
Aims are outlined. Specific Aim 1 details the plans for cloning, expression and
large-scale production of two PBPs, one from Escherichia coli (a Gram-negative
bacterium) and another from Staphylococcus aureus (a Gram-positive bacterium).
These proteins will be used in the biochemical studies and also will be
provided to Professor Judy Kelly of the University of Connecticut for
crystallization. Specific Aim 2 describes our design and proposed syntheses for
two cephalosporins that are incorporated with structural components of the cell
wall (peptidogylcan). These cephalosporins, in conjunction with one that is
already synthesized, are proposed as mechanistic probes for the transpeptidase
reaction carried out by certain PBP in the last step of cell wall biosynthesis
(cross-linking of cell wall). Biochemical and structural experiments are
detailed for the use of these cephalosporins as probes of mechanisms for PBPs.
An assay for the cell wall cross-linking reaction of the transpeptidases (a
PBP) is described in Specific Aim 3. The enzymic reaction is biochemically
dissected into the acylation and deacylation steps, for each of which a
quantitative assay method is described. These methodologies will allow
investigations of the mechanistic details of these PBPs. Furthermore, a series
of four peptidoglycan derivatives have been proposed to investigate the
requirements for a minimal substrate for the transpeptidation reaction of the
PBPs. Specific Aim 4 details the search for novel non-f3-lactam inhibitors for
PBPs. These molecules will be synthesized and their potential PBP inhibitory
and antibacterial activities will be investigated in both in vivo and in vitro
experiments.
描述:(申请人的描述)青霉素结合蛋白(PBP)是一种
一组酶,参与组装中的许多功能,
调节细菌细胞壁。这些酶是β-内酰胺的目标
抑制细菌生长的抗生素。多学科方法
已经概述了PBPs的研究,它建立在机械的基础上,
该实验室的研究结果作为初步结果呈现。具体倾注量
目标已概述。具体目标1详细说明了克隆、表达和
两种PBP的大规模生产,一种来自大肠杆菌(革兰氏阴性菌),
细菌)和另一种来自金黄色葡萄球菌(革兰氏阳性细菌)。
这些蛋白质将用于生物化学研究,也将用于
提供给康涅狄格大学的朱迪·凯利教授
晶化具体目标2描述了我们的设计和建议的合成,
与细胞结构成分结合的两种头孢菌素
壁(肽聚糖)。这些头孢菌素,与一种
已经合成,提出作为转肽酶的机制探针
在细胞壁生物合成的最后一步由某些PBP进行的反应
(细胞壁的交联)。生化和结构实验是
详细介绍了这些头孢菌素作为PBPs机制探针的用途。
转肽酶(a)的细胞壁交联反应的测定
具体目标3中描述了PBP)。酶反应是生物化学反应
分解为酰化和脱酰化步骤,对于每个步骤,
描述了定量测定方法。这些方法将允许
这些PBP的机制细节的调查。此外,A系列
四种肽聚糖衍生物已被提出来研究
用于酶的转肽反应的最小底物的要求
PBPs。具体目标4详细介绍了寻找新型非f3-内酰胺抑制剂,
PBPs。这些分子将被合成并具有潜在的PBP抑制作用
并在体内和体外研究其抗菌活性
实验
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shahriar Mobashery其他文献
Shahriar Mobashery的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shahriar Mobashery', 18)}}的其他基金
Bulgecin Template for Potentiation of beta-Lactam Antibiotics
用于增强 β-内酰胺抗生素的 Bulgecin 模板
- 批准号:
10040793 - 财政年份:2020
- 资助金额:
$ 24.27万 - 项目类别:
Bulgecin Template for Potentiation of beta-Lactam Antibiotics
用于增强 β-内酰胺抗生素的 Bulgecin 模板
- 批准号:
10203804 - 财政年份:2020
- 资助金额:
$ 24.27万 - 项目类别:
Bulgecin Template for Potentiation of beta-Lactam Antibiotics
用于增强 β-内酰胺抗生素的 Bulgecin 模板
- 批准号:
10631928 - 财政年份:2020
- 资助金额:
$ 24.27万 - 项目类别:
Bulgecin Template for Potentiation of beta-Lactam Antibiotics
用于增强 β-内酰胺抗生素的 Bulgecin 模板
- 批准号:
10438764 - 财政年份:2020
- 资助金额:
$ 24.27万 - 项目类别:
Cell-Wall Recycling and Nexus to Antibiotic Resistance
细胞壁回收及其与抗生素耐药性的关系
- 批准号:
10401291 - 财政年份:2019
- 资助金额:
$ 24.27万 - 项目类别:
Cell-Wall Recycling and Nexus to Antibiotic Resistance
细胞壁回收及其与抗生素耐药性的关系
- 批准号:
10627796 - 财政年份:2019
- 资助金额:
$ 24.27万 - 项目类别:
Cell-Wall Recycling and Nexus to Antibiotic Resistance
细胞壁回收及其与抗生素耐药性的关系
- 批准号:
9920167 - 财政年份:2019
- 资助金额:
$ 24.27万 - 项目类别:
Inducible Antibiotic Resistance in Methicillin-Resistant Staphylococcus Aureus
耐甲氧西林金黄色葡萄球菌诱导的抗生素耐药性
- 批准号:
8600959 - 财政年份:2013
- 资助金额:
$ 24.27万 - 项目类别:
Inducible Antibiotic Resistance in Methicillin-Resistant Staphylococcus aureus
耐甲氧西林金黄色葡萄球菌诱导的抗生素耐药性
- 批准号:
10083692 - 财政年份:2013
- 资助金额:
$ 24.27万 - 项目类别:
Beta-Lactam Resistance Mechanisms of Staphylococcus aureus
金黄色葡萄球菌的β-内酰胺耐药机制
- 批准号:
10586370 - 财政年份:2013
- 资助金额:
$ 24.27万 - 项目类别:
相似海外基金
Characterization of Staphylococcus aureus susceptibility to antibiotics in Synthetic Wound Fluid
合成伤口液中金黄色葡萄球菌对抗生素敏感性的表征
- 批准号:
486168 - 财政年份:2022
- 资助金额:
$ 24.27万 - 项目类别:
Studentship Programs
Overcoming antibiotics of last resort: determining the role of compensatory mutations in promoting vancomycin resistance in Staphylococcus aureus
克服最后手段的抗生素:确定补偿突变在促进金黄色葡萄球菌万古霉素耐药性中的作用
- 批准号:
9895973 - 财政年份:2020
- 资助金额:
$ 24.27万 - 项目类别:
Improving on nature: diversifying glycopeptide antibiotics to kill the bacterial pathogen Staphylococcus aureus
改善自然:多样化糖肽抗生素杀死细菌病原体金黄色葡萄球菌
- 批准号:
nhmrc : GNT1140619 - 财政年份:2018
- 资助金额:
$ 24.27万 - 项目类别:
Career Development Fellowships
Improving on nature: diversifying glycopeptide antibiotics to kill the bacterial pathogen Staphylococcus aureus
改善自然:多样化糖肽抗生素杀死细菌病原体金黄色葡萄球菌
- 批准号:
nhmrc : 1140619 - 财政年份:2018
- 资助金额:
$ 24.27万 - 项目类别:
Career Development Fellowships
Development of New Antibiotics Against Multidrug-Resistant Staphylococcus aureus
抗多重耐药金黄色葡萄球菌新型抗生素的研制
- 批准号:
9301456 - 财政年份:2016
- 资助金额:
$ 24.27万 - 项目类别:
New mechanism of resistance to oxazolidinone antibiotics in Staphylococcus aureus
金黄色葡萄球菌对恶唑烷酮类抗生素耐药的新机制
- 批准号:
7433903 - 财政年份:2007
- 资助金额:
$ 24.27万 - 项目类别:
New mechanism of resistance to oxazolidinone antibiotics in Staphylococcus aureus
金黄色葡萄球菌对恶唑烷酮类抗生素耐药的新机制
- 批准号:
7634572 - 财政年份:2007
- 资助金额:
$ 24.27万 - 项目类别:
New mechanism of resistance to oxazolidinone antibiotics in Staphylococcus aureus
金黄色葡萄球菌对恶唑烷酮类抗生素耐药的新机制
- 批准号:
7900588 - 财政年份:2007
- 资助金额:
$ 24.27万 - 项目类别:
New mechanism of resistance to oxazolidinone antibiotics in Staphylococcus aureus
金黄色葡萄球菌对恶唑烷酮类抗生素耐药的新机制
- 批准号:
7318532 - 财政年份:2007
- 资助金额:
$ 24.27万 - 项目类别:
Elucidation of the molecular basis of pseudoresistance to antibiotics in Staphylococcus aureus
阐明金黄色葡萄球菌对抗生素假耐药性的分子基础
- 批准号:
G0501247/1 - 财政年份:2006
- 资助金额:
$ 24.27万 - 项目类别:
Research Grant














{{item.name}}会员




